Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 41.6 Million shares, which have been reported (via 13F filing form) to have a value of $641 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sterling Capital Management LLC
Charlotte, NC |
May 13, 2025 Q1 2025 |
195
shares
|
$3,004
0.0% of portfolio
|
Q1 2025
Reduced 38.49%
|
|
True Wealth Design, LLC
Akron, OH |
May 13, 2025 Q1 2025 |
178
shares
|
$2,742
0.0% of portfolio
|
Q1 2025
New holding
|
|
Daiwa Securities Group Inc.
Tokyo, M0 |
May 13, 2025 Q1 2025 |
160
shares
|
$2,465
0.0% of portfolio
|
Q3 2024
Added 233.33%
|
|
Skopos Labs, Inc.
Riverhead, NY |
May 13, 2025 Q1 2025 |
74
shares
|
$1,140
0.0% of portfolio
|
Q1 2025
New holding
|
|
Ever Source Wealth Advisors, LLC
|
May 13, 2025 Q1 2025 |
74
shares
|
$1,140
0.0% of portfolio
|
Q1 2025
Added 825.0%
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
67
shares
|
$1,032
0.0% of portfolio
|
Q4 2024
New holding
|
|
South State Corp
|
May 12, 2025 Q1 2025 |
56
shares
|
$862
0.0% of portfolio
|
Q1 2025
New holding
|
|
Lazard Asset Management LLC
New York, NY |
May 15, 2025 Q1 2025 |
56
shares
|
$862
0.0% of portfolio
|
Q1 2025
Reduced 99.12%
|
|
Coldstream Capital Management Inc
|
May 13, 2025 Q1 2025 |
29
shares
|
$446
0.0% of portfolio
|
Q1 2025
New holding
|
|
Nisa Investment Advisors, LLC
|
Apr 30, 2025 Q1 2025 |
28
shares
|
$431
0.0% of portfolio
|
Q1 2025
Reduced 6.67%
|
|
Rothschild Investment LLC
Chicago, IL |
Apr 08, 2025 Q1 2025 |
25
shares
|
$385
0.0% of portfolio
|
Q1 2025
Reduced 68.75%
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Jul 11, 2025 Q2 2025 |
1
shares
|
$15
0.0% of portfolio
|
Q1 2025
Reduced 91.67%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|